HANLY ANN M. 4
4 · Vir Biotechnology, Inc. · Filed Feb 26, 2024
Insider Transaction Report
Form 4
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
- Sale
Common Stock
2024-02-22$10.05/sh−12,296$123,521→ 134,780 total - Award
Stock Option (Right to Buy)
2024-02-22+65,000→ 65,000 totalExercise: $10.11Exp: 2034-02-21→ Common Stock (65,000 underlying) - Award
Common Stock
2024-02-22+32,500→ 147,076 total
Holdings
- 11.52(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F3]The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.
- [F4]25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter.